via Phys.org
Multiplexed gene activation system allows for four to six times the activation capacity of current CRISPR technology, with simultaneous activation of up to seven genes at once
In a study in Nature Plants, Yiping Qi, associate professor of Plant Science at the University of Maryland (UMD), introduces a new and improved CRISPR 3.0 system in plants, focusing on gene activation instead of traditional gene editing. This third generation CRISPR system focuses on multiplexed gene activation, meaning that it can boost the function of multiple genes simultaneously. According to the researchers, this system boasts four to six times the activation capacity of current state-of-the-art CRISPR technology, demonstrating high accuracy and efficiency in up to seven genes at once. While CRISPR is more often known for its gene editing capabilities that can knock out genes that are undesirable, activating genes to gain functionality is essential to creating better plants and crops for the future.
“While my lab has produced systems for simultaneous gene editing [multiplexed editing] before, editing is mostly about generating loss of function to improve the crop,” explains Qi. “But if you think about it, that strategy is finite, because there aren’t endless genes that you can turn off and actually still gain something valuable. Logically, it is a very limited way to engineer and breed better traits, whereas the plant may have already evolved to have different pathways, defense mechanisms, and traits that just need a boost. Through activation, you can really uplift pathways or enhance existing capacity, even achieve a novel function. Instead of shutting things down, you can take advantage of the functionality already there in the genome and enhance what you know is useful.”
In his new paper, Qi and his team validated the CRISPR 3.0 system in rice, tomatoes, and Arabidopsis (the most popular model plant species, commonly known as rockcress). The team showed that you can simultaneously activate many kinds of genes, including faster flowering to speed up the breeding process. But this is just one of the many advantages of multiplexed activation, says Qi.
“Having a much more streamlined process for multiplexed activation can provide significant breakthroughs. For example, we look forward to using this technology to screen the genome more effectively and efficiently for genes that can help in the fight against climate change and global hunger. We can design, tailor, and track gene activation with this new system on a larger scale to screen for genes of importance, and that will be very enabling for discovery and translational science in plants.”
Since CRISPR is usually thought of as “molecular scissors” that can cut DNA, this activation system uses deactivated CRISPR-Cas9 that can only bind. Without the ability to cut, the system can focus on recruiting activation proteins for specific genes of interest by binding to certain segments of DNA instead. Qi also tested his SpRY variant of CRISPR-Cas9 that greatly broadens the scope of what can be targeted for activation, as well as a deactivated form of his recent CRISPR-Cas12b system to show versatility across CRISPR systems. This shows the great potential of expanding for multiplexed activation, which can change the way genome engineering works.
“People always talk about how individuals have potential if you can nurture and promote their natural talents,” says Qi. “This technology is exciting to me because we are promoting the same thing in plants – how can you promote their potential to help plants do more with their natural capabilities? That is what multiplexed gene activation can do, and it gives us so many new opportunities for crop breeding and enhancement.”
Original Article: UMD Associate Professor Introduces New CRISPR 3.0 System for Highly Efficient Gene Activation in Plants
More from: University of Maryland
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
CRISPR 3.0
- Outcomes in Children Treated for Perineal Group A Beta-hemolytic Streptococcal Dermatitis
Objectives: To evaluate reports that describe relapse or recurrence following treatment of perineal streptococcal dermatitis (PSD), we studied a large cohort of children with these perianal or ...
- Enhanced CRISPR method enables stable insertion of large genes into the DNA of higher plants
To do this, they optimized the gene-editing method CRISPR/Cas, commonly known as "genetic scissors." The improved CRISPR method offers great opportunities for the targeted modification of genes in ...
- SPGP: A Great Dividend ETF Bargain For Today's Economy
In a market of rising fear and nervous investors worried about earnings season, wouldn't it be wonderful to be able to buy an ETF that was well positioned for today's economy? Not just the current ...
- Lance Zierlein 2024 NFL mock draft 3.0: Giants trade up for QB Drake Maye; WR Ladd McConkey to Chiefs
As we move closer to the actual NFL draft, I try to lock in my mock process by venturing into each general manager's headspace and hypothesizing what the thinking could be relative to draft ...
- RAMI 4.0 Reference Architectural Model for Industrie 4.0
The RAMI 4.0, Reference Architecture Model Industrie 4.0 (Industry 4.0), was developed by the German Electrical and Electronic Manufacturers' Association (ZVEI) to support Industry 4.0 initiatives, ...
Go deeper with Google Headlines on:
CRISPR 3.0
[google_news title=”” keyword=”CRISPR 3.0″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Gene activation
- Genomic analysis of a species of zooplankton questions assumptions about speciation and gene regulation
When two animals look the same, eat the same, behave the same way, and live in similar environments, one might expect that they belong to the same species.
- Startling Discovery: Cancer Can Arise Without Genetic Mutations
A new study reveals that cancer can develop purely from epigenetic changes, challenging the conventional belief that genetic mutations are necessary for the disease. A research team including ...
- Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.
- Apollomics Announces Approval of Vebreltinib in China as a First-in-Class Treatment for Gliomas with MET Fusion Gene
Apollomics’ partner in China, Avistone, received approval from National Medical Products Administration of China to expand the use of vebreltinib to the treatment of gliomas with PTPRZ1-MET fusion ...
- Scientists discover the cellular functions of a family of proteins integral to inflammatory diseases
In a scientific breakthrough, researchers have revealed the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate immune system cells linked to ...
Go deeper with Google Headlines on:
Gene activation
[google_news title=”” keyword=”gene activation” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]